首页> 外文会议>Meeting of the European Colloid and Interface Society >Membrane Affinity of New Antitubercular Drug Candidates Using a Phospholipid Langmuir Monolayer Model and LB Technique
【24h】

Membrane Affinity of New Antitubercular Drug Candidates Using a Phospholipid Langmuir Monolayer Model and LB Technique

机译:使用磷脂Langmuir Monolayer Model和LB技术使用磷脂蛋白候选者的膜亲和力

获取原文

摘要

Tuberculosis is a major problem throughout the world causing 1.9 million deaths annually, and induces a major global public health problem. The pathogen responsible for the disease is Mycobacterium tuberculosis. Drug candidates expected to be specific inhibitors of dUTPase an essential enzyme of Mycobacterium tuberculosis were identified in silico. A phospholipid Langmuir monolayer formed at the liquid/air interface as a simple but versatile model of the cell membrane was applied to assess the membrane affinity of the drug candidates. The interaction of three different potential drug molecules TB501, TB502, and TB505 with lipid monolayer was characterised by tensiometry, and atomic force microscopy at different temperatures. The degree of penetration of drug candidates into the lipid film and the structural variation of drug penetrated lipid films revealed by atomic force microscopic images were compared.
机译:结核病是全世界的主要问题,每年造成160万人死亡,并突出了一个主要的全球公共卫生问题。负责这种疾病的病原体是结核分枝杆菌。预计抑制抑制抑制剂的药物候选者的特异性抑制剂在硅中鉴定了结核分枝杆菌的基本酶。在液体/空气界面处形成的磷脂曲调单层作为细胞膜的简单但通用模型,以评估药物候选物的膜亲和力。三种不同潜在药物TB501,TB502和TB505与脂质单层的相互作用的特征在于张力学,并在不同温度下的原子力显微镜。将药物候选物渗透到脂膜中的渗透程度以及由原子力微观图像显示的药物穿透脂质膜的结构变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号